Retinal Vasculitis

04/01/2020 - "Early systemic steroids might be effective in the treatment of "active" retinal vasculitis."
09/01/2021 - "TB retinal vasculitis was the most common presentation of OTB in this study and OTB generally requires treatment with either regional or systemic steroid together with ATT."
12/01/2008 - "Wegener's retinal vasculitis was diagnosed initially and the patient received treatment with oral steroids. "
01/01/2008 - "In some cases of recurrent isolated retinal vasculitis, a short treatment course of immunosuppressive and systemic steroids can be enough for resolution."
11/01/2007 - "Retinal vasculitis was uncontrolled in a patient treated with steroids. "

01/30/2023 - "Fluorescein angiography is the gold standard test to assess retinal vasculitis, but is invasive and time-consuming. "
02/01/2017 - "Fluorescein angiography is the gold standard in revealing the extent and severity as well as the leaky and/or occlusive nature of retinal vasculitis. "
02/11/2013 - "The purpose of this study is to describe and quantify the benefit of ultra-wide-field imaging and fluorescein angiography (FA) in the management of non-infectious retinal vasculitis. "
12/01/2023 - "Fluorescein angiography revealed bilateral occlusive retinal vasculitis. "
08/04/2023 - "A 61-year-old, South-East Asian man, developed CMV-related endotheliitis and occlusive retinal vasculitis, diagnosed by wide-angle fluorescein angiography. "

01/01/1994 - "This study was undertaken to assess the efficacy of a standard regime of high-dose systemic oral corticosteroids in the management of retinal vasculitis. "
01/01/1994 - "The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis."
05/01/2023 - "Recovery was complicated by acute post-infectious retinal vasculitis after tapering high-dose corticosteroids, requiring an extended corticosteroid regimen over 2 months until resolution. "
10/01/2022 - "Systemic corticosteroids were administered without the use of antituberculosis drugs to all 16 cases of presumed tuberculous retinal vasculitis associated with positive QFT (26 eyes), 10 (63%) of whom were given nonsteroidal immunosuppressive drugs and achieved inflammatory control and treatment success. "
11/01/2016 - "The retinal vasculitis and the cotton-wool spots resolved after initiation of systemic corticosteroids and his vision returned to normal. "

12/01/2015 - "LONG-TERM EFFICACY OF SYSTEMIC INFLIXIMAB IN RECALCITRANT RETINAL VASCULITIS."
12/01/2015 - "Infliximab is effective for the treatment of recalcitrant noninfectious retinal vasculitis, refractory to conventional immunomodulatory therapy."
12/01/2015 - "Sixty patients received infliximab therapy between July 2007 and July 2012 at Massachusetts Eye Research and Surgery Institution for a diagnosis of retinal vasculitis. "
05/01/2018 - "Evaluation of efficacy of infliximab for retinal vasculitis and extraocular symptoms in Behçet disease."
01/01/2019 - "Infliximab was more effective than CsA in reducing short-term uveitis flares and severe complications of retinal vasculitis in the long term. "

02/15/2023 - "Following treatment with adalimumab for 5 months, FA revealed significant improvement of retinal vasculitis. "
01/01/2021 - "The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal Vasculitis."
07/31/2019 - "Retinal vasculitis resolved in all cases (100%) after starting adalimumab. "
02/15/2023 - "Adalimumab treatment was effective in treating both osteitis and retinal vasculitis."
01/01/2021 - "Background: No study has evaluated the effectiveness of Adalimumab (ADA) as first-line in treatment-naïve patients with retinal vasculitis due to Behçet's Uveitis (BU). "

11/23/2023 - "To define the incidence of the adverse events, Novartis convened an external safety review committee, which found a rate of 4.6% for definite or probable IOI, 3.3% for retinal vasculitis, and 2.1% for retinal vascular occlusion in the HAWK and HARRIER trials. "
01/30/2023 - "Five OCT studies reported secondary complications could be detected, and four reported retinal thickness alteration in retinal vasculitis. "
01/01/2022 - "However, incidences of IOI, including retinal vasculitis and retinal vascular occlusion, also were higher, leading to study termination."
11/28/2023 - "Retinal vasculitis and/or retinal occlusion (RV and/or RO) occurred in 53 eyes (3.9%). "
11/01/2023 - "Although HIV is most classically associated with a retinal microangiopathy, testing should be considered in cases of occlusive retinal vasculitis because it is a rare cause of such findings."

06/01/2023 - "To describe results of treatment of idiopathic retinal vasculitis with intravenous rituximab. "
06/01/2023 - "Successful treatment of idiopathic retinal vasculitis with rituximab in two patients."
03/01/2018 - "Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis."
01/01/2018 - "Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis: Erratum."
01/01/2018 - "Rituximab should be considered as an initial treatment for patients with refractory retinal vasculitis associated with AAV."

12/01/2023 - "Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor."
01/01/2022 - "A total of 330 patients (median age, 36 years; interquartile range, 27-54), 45.2% men) with sight-threatening NIU (ie, retinal vasculitis and/or macular edema) treated with anti-tumor necrosis factor [TNF]-α agents (IFX intravenously at 5 mg/kg at weeks 0, 2, 6, and every 4 to 6 weeks or ADA subcutaneously at 80 mg, then 40 mg every 2 weeks). "
12/01/2023 - "Both the patient's retinal vasculitis and skin patches responded favorably to treatment with adalimumab, a TNF-alpha inhibitor. "
12/01/2023 - "To report the clinical and histopathologic features of necrobiosis lipoidica and associated retinal vasculitis and describe successful treatment of both skin and eye manifestations with adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. "
10/01/2018 - "The primary aim of the study was to evaluate the efficacy of tumor necrosis factor (TNF)-α blockers adalimumab (ADA) and infliximab (IFX) in refractory sight-threatening retinal vasculitis (RV) during a 12-month follow-up period. "

01/01/1992 - "In a prospective, open clinical trial, we studied long-term effects of cyclosporine (CsA) on the optic nerve and retinal vasculitis in 14 Behçet's disease patients. "
01/01/1992 - "Cyclosporine effects on optic nerve and retinal vasculitis in Behçet's disease."
01/01/1992 - "A further 4 patients with retinal vasculitis who had been treated with cyclosporin A demonstrated a 32% reduction in IL2-R expression over a 3-month period. "
07/01/2000 - "A 73-year-old woman with panuveitis and retinal vasculitis presented with a lump on her lip after 52 months of treatment with cyclosporin A. "
05/01/1994 - "We used cyclosporin A (CA) to treat 14 patients (25 eyes) with Behçet's disease characterized by severe retinal vasculitis and active intraocular inflammation. "

04/01/2006 - "The efficacy of interferon needs to be evaluated in other etiologies of retinal vasculitis through randomized studies."
01/01/2007 - "Here we show that type 1 interferons (IFN alpha/beta) were not detected in sera from normal individuals but were identified in up to 46% of the sera from retinal vasculitis patients. "
04/01/2006 - "[Interferon and retinal vasculitis]."
09/01/2018 - "This treatment does not appear to be sufficient for severe uveitis with reduced visual acuity or retinal vasculitis that requires anti-TNF α or interferon α. "
01/01/2014 - "Interferon has been useful to control inflammation and induce neovascular regression in retinal vasculitis secondary to Behçet's disease and multiple sclerosis. "

01/01/2021 - "Objective: To compare the efficacy of ADA plus conventional therapy and conventional therapy alone as initial treatments in naïve BU patients characterized by retinal vasculitis. "
04/01/2021 - "However, few studies in the far easter region have concentrated on this therapy and current studies have not emphasized the elimination of retinal vasculitis. "
10/01/2022 - "After a median (interquartile range [IQR]) treatment time of 28.5 (8-43) months, anti-CD20 therapy was associated with an improvement of vitreous haze score (p = 0.002), retinal vasculitis score (p = 0.001), CRT (p = 0.002), and VA (p = 0.007). "
01/01/2022 - "Feasibility of standalone antitubercular therapy for retinal vasculitis."
01/01/2022 - "Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis."

02/01/2019 - "A 28-year-old man, who initially presented with occlusive retinal vasculitis and vitreous hemorrhage in right eye that resolved with sectoral photocoagulation. "
04/01/2000 - "Occlusive peripheral retinal vasculitis with subsequent areas of ischaemia and neovascularization requiring panretinal laser photocoagulation developed in eight eyes, five of which also required vitrectomy. "
01/01/2020 - "Here, we describe a patient with early idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome, who was treated with a combination of systemic immunosuppression and localized photocoagulation. "
01/01/2020 - "TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS (IRVAN) WITH PHOTOCOAGULATION IN COMBINATION WITH SYSTEMIC IMMUNOSUPPRESSION."
11/01/2002 - "Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease)."

04/01/2017 - "Systemic immunomodulatory therapy can be effective in managing and leading to resolution of MFC, retinal vasculitis, and optic disc leak in young patients."
01/01/2020 - "Failure to control occult retinal vasculitis adequately may be a contributing factor to seemingly recalcitrant cases, inability to wean off immunomodulatory therapy, and long-term complications leading to poor prognosis."
08/04/2023 - "Cytomegalovirus anterior uveitis and occlusive retinal vasculitis without retinitis in a patient on immunomodulatory therapy."
12/01/2015 - "Infliximab is effective for the treatment of recalcitrant noninfectious retinal vasculitis, refractory to conventional immunomodulatory therapy."
10/01/2018 - "Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies."

01/01/2019 - "In clinical practice, patients with Behcet's disease with retinal vasculitis who received MSC injections experienced a decrease in retinal vasculitis but no improvement in vision acuity. Nonetheless, there is no evidence that MSCs are carcinogenic, and they even reduce the size of tumors in vitro. "
05/01/2022 - "Although the injections are generally well tolerated, sight-threatening complications can occur including endophthalmitis, retinal detachment, and/or retinal vasculitis. "
07/01/2023 - "In total, 1 patient (1.2%) with idiopathic retinal vasculitis, aneurysms and neuroretinitis was treated with IDI injections in both eyes in addition to systemic therapy to reduce the ongoing inflammation. "
07/01/2022 - "EFFICACY OF INTRAVITREAL AFLIBERCEPT INJECTIONS IN THE TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS SYNDROME."
07/01/2022 - "To present a case of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome that was successfully managed with serial intravitreal aflibercept injections. "

11/01/2022 - "Streptococcus salivarius is a virulent organism that may cause an endophthalmitis early after intravitreal injection with an unusual presentation of hemorrhagic retinal vasculitis. "
11/01/2022 - "We describe a case of endophthalmitis caused by Streptococcus salivarius presenting as a retinal vasculitis less than 24 hours after intravitreal injection. "
01/01/2022 - "Retinal vasculitis after intravitreal injection of brolucizumab."
01/01/2022 - "[Intraocular inflammation with occlusive retinal vasculitis following intravitreal injection of brolucizumab]."
07/01/2021 - "The result of this single intravitreal injection of ranibizumab was sustained; best-corrected visual acuity remained unchanged (20/20 in both eyes), and no recurrence of cystoid macular edema or retinal vasculitis was found after 4-year follow-up. "